SecBot SecBot
425 ·Filed May 7, 2026

PEN

Penumbra Inc
BULLISH
Impact 7/10
Horizonweeks Processed6mo ago SEC0001321732-26-000025
Rule 425 M&A communications
Actionable Insight ▲ Bullish

The shareholder vote removes a key condition to closing. Focus now shifts to regulatory approvals, particularly HSR and non-U.S. antitrust clearances. Monitor for updates on these fronts; any delay or condition could affect the timeline. The expected close in H2 2026 remains intact per Boston Scientific's Q1 call.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$324.65
T+0 close · May 7, 2026 · via day close
Latest settled
−0.50%
T+60 · $323.02
Vs SPY
−4.34%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $324.65entry
  2. T+1 · 6mo ago −0.75%α −1.58% · $322.23
  3. T+5 · 6mo ago −0.63%α −2.14% · $322.59
  4. T+20 · 6mo ago −1.63%α −4.76% · $319.37
  5. T+60 · 4mo ago −0.50%α −4.34% · $323.02
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Penumbra shareholders voted overwhelmingly to approve the merger with Boston Scientific, with 99.7% of votes cast in favor. The deal now awaits remaining regulatory clearances (HSR and foreign antitrust) and is expected to close in the second half of 2026.

Key Financial Metrics

Deal Type
merger

Key Facts

  • 28,564,786 votes FOR the merger (99.7% of cast votes), 85,334 AGAINST, 15,813 abstentions
  • 28,665,933 shares present or proxy out of 39,324,084 outstanding (72.9% quorum)
  • Advisory compensation proposal also approved (27,811,605 FOR)
  • Merger agreement dated January 14, 2026; Penumbra to survive as wholly owned subsidiary of Boston Scientific
  • Remaining conditions: HSR waiting period expiration/termination and non-U.S. antitrust/foreign investment clearances

Financial Impact

No financial figures disclosed in this filing; deal value and terms are in prior merger agreement filings.

Risk Factors

  • Failure to obtain remaining regulatory approvals (HSR, foreign antitrust/investment clearances)
  • Potential for regulatory conditions that could alter deal terms or timeline

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
36% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001321732-26-000025
Document: 0001321732-26-000025-index-headers.html0001321732-26-000025
Document: 0001321732-26-000025-index.html0001321732-26-000025
Document: 0001321732-26-000025.txt0001321732-26-000025

Track record

11 reports on PEN

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +1.63% at T+20 after the May 6, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $321.46 Now $320.62 −0.26% settles Feb 8
  2. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $319.21 Now $320.62 +0.44% settles Feb 4
  3. Oct 29, 202618d ago 8-K Neutral 5/10 No price data
  4. Oct 29, 202618d ago Press Release Neutral 5/10 Entry $318.95 Now $320.62 +0.52% settles Jan 28
  5. Jul 30, 202615w ago Press Release Bearish 6/10 Entry $321.19 to $325.22 Now $320.62 +0.18% ▼ −1.25% +1.20% vs SPY
  6. May 7, 202627w ago 425 Bullish 7/10 Viewing Entry $324.65 to $323.02 Now $320.62 −1.24% ▼ −0.50% −4.34% vs SPY
  7. May 6, 202627w ago 8-K Bearish 6/10 Entry $324.65 to $323.02 Now $320.62 +1.24% ▲ +0.50% +4.34% vs SPY
  8. Apr 29, 202628w ago DEFA14A Neutral 2/10 Entry $326.48 to $319.49 Now $320.62 −1.79% ▼ −2.14% −5.25% vs SPY
  9. Apr 17, 202630w ago 425 Neutral 4/10 Entry $329.71 to $316.73 Now $320.62 −2.76% ▼ −3.94% −10.71% vs SPY
  10. Apr 1, 202632w ago DEFM14A Bullish 8/10 Entry $330.36 to $315.75 Now $320.62 −2.95% ▼ −4.42% −18.58% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026